Cliff Asness's MED Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 145,575 shares of Medifast, Inc. (MED) worth $1.48 M, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 54 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in MED, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2024, adding 210,669 shares. Largest reduction occurred in Q4 2024, reducing 210,214 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Medifast (MED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medifast (MED) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +14,066 | Add 10.70% | 145,575 | $10.19 |
| Q4 2025 | -179,310 | Reduce 57.69% | 131,509 | $10.68 |
| Q3 2025 | +90,688 | Add 41.20% | 310,819 | $13.67 |
| Q2 2025 | +20,381 | Add 10.20% | 220,131 | $14.05 |
| Q1 2025 | +25,366 | Add 14.55% | 199,750 | $13.48 |
| Q4 2024 | -210,214 | Reduce 54.66% | 174,384 | $17.62 |
| Q3 2024 | -5,353 | Reduce 1.37% | 384,598 | $19.14 |
| Q2 2024 | +210,669 | Add 117.51% | 389,951 | $21.82 |
| Q1 2024 | +68,866 | Add 62.37% | 179,282 | $38.32 |
| Q4 2023 | -11,255 | Reduce 9.25% | 110,416 | $67.22 |
| Q3 2023 | +19,192 | Add 18.73% | 121,671 | $74.85 |
| Q2 2023 | +21,927 | Add 27.22% | 102,479 | $92.16 |
| Q1 2023 | +38,969 | Add 93.71% | 80,552 | $103.67 |
| Q4 2022 | +29,369 | Add 240.45% | 41,583 | $115.35 |
| Q3 2022 | +8,030 | Add 191.92% | 12,214 | $108.40 |
| Q2 2022 | -3,952 | Reduce 48.57% | 4,184 | $180.45 |
| Q1 2022 | -3,640 | Reduce 30.91% | 8,136 | $170.72 |
| Q4 2021 | -783 | Reduce 6.23% | 11,776 | $209.41 |
| Q3 2021 | -1,880 | Reduce 13.02% | 12,559 | $192.61 |
| Q2 2021 | +1,473 | Add 11.36% | 14,439 | $282.98 |
| Q1 2021 | -762 | Reduce 5.55% | 12,966 | $211.78 |
| Q4 2020 | +4,566 | Add 49.84% | 13,728 | $196.31 |
| Q3 2020 | +6,811 | Add 289.71% | 9,162 | $164.48 |
| Q2 2020 | +2,351 | New Buy | 2,351 | $138.66 |
| Q1 2020 | -10,853 | Sold Out | 0 | $0.00 |
| Q4 2019 | -76,992 | Reduce 87.65% | 10,853 | $109.55 |
| Q3 2019 | -17,043 | Reduce 16.25% | 87,845 | $103.63 |
| Q2 2019 | -18,882 | Reduce 15.26% | 104,888 | $128.30 |
| Q1 2019 | -8,101 | Reduce 6.14% | 123,770 | $127.55 |
| Q4 2018 | -261 | Reduce 0.20% | 131,871 | $125.02 |
| Q3 2018 | +77,097 | Add 140.09% | 132,132 | $221.55 |
| Q2 2018 | +39,269 | Add 249.07% | 55,035 | $160.15 |
| Q1 2018 | -12,003 | Reduce 43.22% | 15,766 | $93.43 |
| Q4 2017 | -13,054 | Reduce 31.98% | 27,769 | $69.83 |
| Q3 2017 | -56,378 | Reduce 58.00% | 40,823 | $59.38 |
| Q2 2017 | -22,494 | Reduce 18.79% | 97,201 | $41.47 |
| Q1 2017 | -13,036 | Reduce 9.82% | 119,695 | $44.37 |
| Q4 2016 | -2,562 | Reduce 1.89% | 132,731 | $41.63 |
| Q3 2016 | +23,753 | Add 21.30% | 135,293 | $37.79 |
| Q2 2016 | -2,646 | Reduce 2.32% | 111,540 | $33.27 |
| Q1 2016 | -3,911 | Reduce 3.31% | 114,186 | $30.19 |
| Q4 2015 | -8,939 | Reduce 7.04% | 118,097 | $30.38 |
| Q3 2015 | -26,071 | Reduce 17.03% | 127,036 | $26.86 |
| Q2 2015 | -8,883 | Reduce 5.48% | 153,107 | $32.32 |
| Q1 2015 | +17,227 | Add 11.90% | 161,990 | $29.97 |
| Q4 2014 | +57,022 | Add 64.99% | 144,763 | $33.55 |
| Q3 2014 | +3,700 | Add 4.40% | 87,741 | $32.84 |
| Q2 2014 | -49,300 | Reduce 36.97% | 84,041 | $30.41 |
| Q1 2014 | -2,000 | Reduce 1.48% | 133,341 | $29.09 |
| Q4 2013 | -19,000 | Reduce 12.31% | 135,341 | $26.13 |
| Q3 2013 | -30,262 | Reduce 16.39% | 154,341 | $26.89 |
| Q2 2013 | +184,603 | Add 0.00% | 184,603 | $25.76 |
| Q4 2012 | +150,903 | Add 0.00% | 150,903 | $26.39 |
Cliff Asness's Medifast Investment FAQs
Cliff Asness first purchased Medifast, Inc. (MED) in Q4 2012, acquiring 150,903 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Medifast, Inc. (MED) for 54 quarters since Q4 2012.
Cliff Asness's largest addition to Medifast, Inc. (MED) was in Q2 2024, adding 389,951 shares worth $8.51 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 145,575 shares of Medifast, Inc. (MED), valued at approximately $1.48 M.
As of the Q1 2026 filing, Medifast, Inc. (MED) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Medifast, Inc. (MED) was 389,951 shares, as reported at the end of Q2 2024.